by

Homepage
Tags search
Peregrine Ventures

CTech 24/7

22:04 Google’s $32 billion acquisition of Wiz draws antitrust attention

More stories in CTech

Peregrine Ventures

8 stories about Peregrine Ventures

Trump's economic policies could boost Israeli tech sectors, says Peregrine Ventures
14.01.25|James Spiro, Elihay Vidal“Israeli companies must remain agile, strengthen ties with U.S. investors and strategic partners, and tailor their innovations to meet the evolving needs of both American and global markets,” said Lior Shahory.
Peregrine Ventures: “2022 seems to be a wake-up year to reality”
01.12.22|Elihay Vidal, James SpiroThe firm spoke to CTech about what this year meant for investment and how next year might change
“There’s almost no important medical technology that’s not completely Israeli or has a big Israeli component”
21.10.22|Yonatan SredniIn an in-depth exclusive interview, Eyal Lifschitz, co-founder & managing general partner of Peregrine Ventures, Israel's first dedicated healthcare VC fund, gets to the heart of Israeli medtech and where it’s headed
Peregrine Ventures announces new consortium to invest over $90 million in medical startups
09.08.22|CTechThe new members of Peregrine’s Incentive Incubator include global pharmaceutical giant Bristol-Myers Squibb (BMS), medical devices and diagnostics company BD (Becton Dickinson and Company), Elbit Systems, and institutions such as Tel Aviv University, Ben-Gurion University of the Negev, and Shaare Zedek Medical Center
Israeli medical device company Memic raises $96 million to expand surgical robotic solution
12.04.21|Meir OrbachThe funding is set to primarily support commercialization of the Hominis surgical robot in the U.S. following FDA De Novo marketing authorization
Who launched a $300 million life science fund and is Waze about to lose its way?
10.11.20|CTechCTech Daily Roundup: Thousands of Israelis risk being blackmailed after network of sexual meetup sites breached
Peregrine Ventures launches $300 million life science fund
10.11.20|Meir OrbachThe venture capital group raised the large sum to finance late stage life science companies, predicts more investments in the sector
Medtronic invests $4.5 million as part of BioProtect $25 million series D
22.09.20|Meir OrbachProceeds of the round will finance the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy

About CTech Terms of Use Privacy Policy

Back to Top